PT1987819E - Forma de administração injetável de flupirtina - Google Patents
Forma de administração injetável de flupirtina Download PDFInfo
- Publication number
- PT1987819E PT1987819E PT08010996T PT08010996T PT1987819E PT 1987819 E PT1987819 E PT 1987819E PT 08010996 T PT08010996 T PT 08010996T PT 08010996 T PT08010996 T PT 08010996T PT 1987819 E PT1987819 E PT 1987819E
- Authority
- PT
- Portugal
- Prior art keywords
- propionic
- acetic
- addition salt
- references cited
- acid addition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Claims (3)
19 REFERENCIAS CITADAS NA DESCRIÇÃO Esta lista de referências citadas pelo requerente é apenas para a conveniência do leitor. A mesma não faz parte do documento de Patente Europeia. Embora muito cuidado tenha sido tomado na compilação das referências, erros e omissões não podem ser excluídos e o EPO nega qualquer responsabilidade neste sentido. Documentos de Patente citados na descrição • DE 4122166 AI • DE 3133519 C2 [0002] [0002] • DE 3416609 AI [0002] • DE 4327516 [0002] [0005] • DE 19541405 AI • DE 9321574 UI [0003] [0002] • DE 4319649 AI [0003] • DE 10048969 AI [0002] • DE 1795858 C2 [0002] 1 REIVINDICAÇÕES 1. Sal de adição de ácido de 2-amino-3-carbetoxiamino-6-p-fluorobenzilamino-piridina [flupirtina], caracterizado pelo facto de o ácido adicionado ser selecionado de entre os ácidos fórmico, acético, propiónico, fenilacético, bem como, ácidos sulfónicos.
2. Sal de adição de ácido de acordo com a reivindicação 1, também caracterizado pelo facto de o ácido adicionado ser selecionado de entre os ácidos fórmico, acético, propiónico, fenilacético, metanossulfónico, etanossulfónico, hidroxietanossulfónico, etilenossulfónico, halogenobenzossulfónico, toluenossulfónico e naftalinossulfónico.
3. Sal de adição de ácido de acordo com a reivindicação 1 ou 2, também caracterizado pelo facto de o ácido adicionado ser selecionado de entre os ácidos acético, propiónico, metanossulfónico, etanossulfónico e toluenossulfónico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10327674A DE10327674A1 (de) | 2003-06-20 | 2003-06-20 | Injizierbare Darreichungsform von Flupirtin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1987819E true PT1987819E (pt) | 2012-07-06 |
Family
ID=33495162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT08010996T PT1987819E (pt) | 2003-06-20 | 2004-06-16 | Forma de administração injetável de flupirtina |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20060252804A1 (pt) |
| EP (2) | EP1638532B1 (pt) |
| JP (1) | JP4617303B2 (pt) |
| KR (1) | KR20060025182A (pt) |
| CN (1) | CN1838943A (pt) |
| AR (1) | AR044831A1 (pt) |
| AT (2) | ATE553085T1 (pt) |
| CA (1) | CA2528899A1 (pt) |
| DE (2) | DE10327674A1 (pt) |
| DK (1) | DK1987819T3 (pt) |
| EA (1) | EA008145B1 (pt) |
| ES (2) | ES2322999T3 (pt) |
| PL (2) | PL1987819T3 (pt) |
| PT (1) | PT1987819E (pt) |
| RS (1) | RS20050941A (pt) |
| TW (1) | TWI343261B (pt) |
| UA (1) | UA84155C2 (pt) |
| WO (1) | WO2004112754A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7592002B2 (en) * | 2005-10-31 | 2009-09-22 | Bioderm Research | Sugar esters for depilation (hair removal), demabrasion, and wrinkles reduction |
| JP5283050B2 (ja) * | 2005-02-07 | 2013-09-04 | 国立大学法人京都大学 | 繊維強化複合材料 |
| EP2052723A4 (en) * | 2006-08-14 | 2010-07-28 | Eisai R&D Man Co Ltd | STABLE LYOPHILIZED PREPARATION |
| US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
| WO2009152168A2 (en) * | 2008-06-09 | 2009-12-17 | Awd. Pharma Gmbh & Co. Kg | Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine |
| WO2009152142A1 (en) * | 2008-06-09 | 2009-12-17 | Awd. Pharma Gmbh & Co. Kg | Sulfonate salts of flupirtine |
| DE102010030053A1 (de) * | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
| DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1795858C2 (de) | 1968-07-19 | 1979-01-11 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Benzylaminopyridine |
| US4481205A (en) * | 1980-09-13 | 1984-11-06 | Degussa Aktiengesellschaft | 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate |
| DE3133519A1 (de) | 1980-09-13 | 1982-06-09 | Degussa Ag, 6000 Frankfurt | "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat" |
| DE3416609A1 (de) * | 1984-05-05 | 1985-11-07 | Degussa Ag, 6000 Frankfurt | 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten |
| JPH0665648B2 (ja) * | 1985-09-25 | 1994-08-24 | 塩野義製薬株式会社 | 白金系抗癌物質の安定な凍結真空乾燥製剤 |
| IN172468B (pt) | 1990-07-14 | 1993-08-14 | Asta Medica Ag | |
| DE9321574U1 (de) * | 1992-03-11 | 2000-06-29 | Asta Medica Ag | Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen |
| DE4319649A1 (de) | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
| DE4327516A1 (de) | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
| GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
| AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
| DE19541405A1 (de) | 1995-11-07 | 1997-05-15 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen |
| JP2781783B2 (ja) * | 1996-07-30 | 1998-07-30 | 山形日本電気株式会社 | 半導体装置用パッケージ |
| US6010719A (en) * | 1997-09-16 | 2000-01-04 | Universiteit Gent | Freeze-dried disintegrating tablets |
| DE10048969A1 (de) | 2000-08-23 | 2002-03-14 | Mueller Schwefe Gerhard | Verwendung von Flupirtin zur Tinnitusbehandlung |
| US7695736B2 (en) * | 2001-04-03 | 2010-04-13 | Pfizer Inc. | Reconstitutable parenteral composition |
-
2003
- 2003-06-20 DE DE10327674A patent/DE10327674A1/de not_active Withdrawn
-
2004
- 2004-06-16 JP JP2006515943A patent/JP4617303B2/ja not_active Expired - Fee Related
- 2004-06-16 ES ES04739918T patent/ES2322999T3/es active Active
- 2004-06-16 EA EA200600070A patent/EA008145B1/ru not_active IP Right Cessation
- 2004-06-16 ES ES08010996T patent/ES2388088T3/es active Active
- 2004-06-16 DK DK08010996.0T patent/DK1987819T3/da active
- 2004-06-16 PL PL08010996T patent/PL1987819T3/pl unknown
- 2004-06-16 CA CA002528899A patent/CA2528899A1/en not_active Abandoned
- 2004-06-16 AT AT08010996T patent/ATE553085T1/de active
- 2004-06-16 CN CNA2004800239267A patent/CN1838943A/zh active Pending
- 2004-06-16 AT AT04739918T patent/ATE423549T1/de not_active IP Right Cessation
- 2004-06-16 KR KR1020057024383A patent/KR20060025182A/ko not_active Application Discontinuation
- 2004-06-16 EP EP04739918A patent/EP1638532B1/de active Active
- 2004-06-16 RS YUP-2005/0941A patent/RS20050941A/sr unknown
- 2004-06-16 UA UAA200600532A patent/UA84155C2/ru unknown
- 2004-06-16 WO PCT/EP2004/006449 patent/WO2004112754A1/de active Application Filing
- 2004-06-16 EP EP08010996A patent/EP1987819B1/de not_active Not-in-force
- 2004-06-16 DE DE502004009045T patent/DE502004009045D1/de active Active
- 2004-06-16 PT PT08010996T patent/PT1987819E/pt unknown
- 2004-06-16 US US10/560,420 patent/US20060252804A1/en not_active Abandoned
- 2004-06-16 TW TW093117391A patent/TWI343261B/zh not_active IP Right Cessation
- 2004-06-16 PL PL04739918T patent/PL1638532T3/pl unknown
- 2004-06-18 AR ARP040102141A patent/AR044831A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1638532A1 (de) | 2006-03-29 |
| ES2388088T3 (es) | 2012-10-08 |
| EA008145B1 (ru) | 2007-04-27 |
| EA200600070A1 (ru) | 2006-06-30 |
| PL1987819T3 (pl) | 2012-09-28 |
| TW200509984A (en) | 2005-03-16 |
| ATE423549T1 (de) | 2009-03-15 |
| RS20050941A (en) | 2007-09-21 |
| DE10327674A1 (de) | 2005-01-05 |
| WO2004112754A1 (de) | 2004-12-29 |
| KR20060025182A (ko) | 2006-03-20 |
| PL1638532T3 (pl) | 2009-07-31 |
| JP4617303B2 (ja) | 2011-01-26 |
| US20060252804A1 (en) | 2006-11-09 |
| AR044831A1 (es) | 2005-10-05 |
| UA84155C2 (ru) | 2008-09-25 |
| ATE553085T1 (de) | 2012-04-15 |
| EP1987819A1 (de) | 2008-11-05 |
| JP2007506660A (ja) | 2007-03-22 |
| CA2528899A1 (en) | 2004-12-29 |
| EP1638532B1 (de) | 2009-02-25 |
| CN1838943A (zh) | 2006-09-27 |
| DK1987819T3 (da) | 2012-07-16 |
| ES2322999T3 (es) | 2009-07-03 |
| EP1987819B1 (de) | 2012-04-11 |
| TWI343261B (en) | 2011-06-11 |
| DE502004009045D1 (de) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1987819E (pt) | Forma de administração injetável de flupirtina | |
| BRPI0410684A (pt) | uso de um peptìdio conjugado a uma proteìna que age como um imunógeno para a produção de anticorpos capazes de reconhecer especificamente qualquer uma das variantes predominantes do peptìdeo beta amilóide aß40 e aß42 na preparação de um medicamento para a prevenção e/ou o tratamento de uma doença e uso de um anticorpo ou um fragmento ativo ou o derivado de um anticorpo que reconhece especificamente qualquer uma das variantes predominantes do peptìdio beta amilóide, aß40 e aß42, na preparação de um medicamento para prevenção e/ou tratamento de uma doença | |
| CY1110881T1 (el) | Παραγωγα κιναζολινης χρησιμα στη θεραπεια περιφερικης αρτηριακης νοσου και ως αναστολεις της φωσφοδιεστερασης | |
| BR0312873A (pt) | 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil] benzamida para tratamento de doenças associadas com ret cinase mutante | |
| DE60315176D1 (de) | Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen | |
| DE602004009166D1 (de) | Neue Analoga von Nitrobenzylthioinosin | |
| Patel et al. | A comparative study of impact on cognitive function between diabetic and non-diabetic patients in a tertiary care hospital | |
| CY1112415T1 (el) | Η πρωτεϊνη serum amyloid p-component (sap, samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down) | |
| BR0009481A (pt) | Dispositivo de regulagem | |
| CN208388828U (zh) | 一种医疗骨科夹板 | |
| Ngamthipwatthana et al. | Efficacy and safety of olanzapine in the treatment of Thai schizophrenic patients. | |
| BRPI0510510A (pt) | espuma ativada feita de uma borracha natural ou sintética ou de uma resina sintética | |
| LEE et al. | Diabetic ketoacidosis in a schizophrenic patient treated with olanzapine: a case report | |
| BR8302492U (pt) | Disposição introduzida em elevador retrátil de automóveis | |
| XU | The Clinical Research of Heart Rate Variability of 88 Diabetes Mellitus Cases with Hypertension and Body Posture Hypotension | |
| CN205181731U (zh) | 一种新型收缩式护理椅 | |
| JP3080691U (ja) | 木製又は合成樹脂等の柄付き発泡硬質ウレタン軽石 | |
| Zhang et al. | Review of important clinical advances in diabetes mellitus in 2015 | |
| Chen et al. | Comparison of the effect of acarbose, metformin and glipizide on newly diagnosed young type 2 diabetic patients | |
| Mireille et al. | Selective grinding for ternporomandibular disorder patients: indications and limits | |
| Wongjirat et al. | The pilot study of the effect of physical therapy with amphetamine in sensorimotor recovery of acute stoke patients. | |
| BR0012274A (pt) | Dna codificante para beta-tubulina e seu uso | |
| Odiit et al. | Selective protein index and clinical features of childhood nephrotic syndrome in Kampala [see comment] | |
| Lee et al. | Erectile response of intracavernous injection of new triple agents, chlorpromazine, papaverine, and alprostadil | |
| Abeer M et al. | Evaluation of adjunctive systemic doxycycline with non-surgical periodontal therapy within type 2 diabetic patients |